ErbB2 regulates cysteine cathepsins B and L in human breast cancer

被引:0
作者
Rafn, Bo [1 ]
机构
[1] Danish Canc Soc, Copenhagen, Zealand, Denmark
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:234 / 234
页数:1
相关论文
共 50 条
[21]   OPTIMIZATION OF IMMUNOHISTOCHEMICAL DETECTION OF ERBB2 IN HUMAN BREAST-CANCER - IMPACT OF FIXATION [J].
PENAULTLLORCA, F ;
ADELAIDE, J ;
HOUVENAEGHEL, G ;
HASSOUN, J ;
BIRNBAUM, D ;
JACQUEMIER, J .
JOURNAL OF PATHOLOGY, 1994, 173 (01) :65-75
[22]   The ErbB2 signaling network as a target for breast cancer therapy [J].
Badache, Ali ;
Goncalves, Anthony .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2006, 11 (01) :13-25
[23]   Brk is coamplified with ErbB2 to promote proliferation in breast cancer [J].
Xiang, Bin ;
Chatti, Kiranam ;
Qiu, Haoqun ;
Lakshmi, B. ;
Krasnitz, Alexander ;
Hicks, Jim ;
Yu, Min ;
Miller, W. Todd ;
Muthuswamy, Senthil K. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (34) :12463-12468
[24]   MiR-34a modulates ErbB2 in breast cancer [J].
Wang, Yilin ;
Zhang, Xiaolong ;
Chao, Zou ;
Kung, Hsiang-Fu ;
Lin, Marie C. ;
Dress, Andreas ;
Wardle, Fiona ;
Jiang, Bing-Hua ;
Lai, Lihui .
CELL BIOLOGY INTERNATIONAL, 2017, 41 (01) :93-101
[25]   The potential role of the EGFR/ERBB2 heterodimer in breast cancer [J].
Cicenas, Jonas .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (06) :607-616
[26]   The ErbB2 Signaling Network as a Target for Breast Cancer Therapy [J].
Ali Badache ;
Anthony Gonçalves .
Journal of Mammary Gland Biology and Neoplasia, 2006, 11 :13-25
[27]   Classification of Breast Cancer According to ERBB2 Immunohistochemistry Scores [J].
Robbins, Charles J. J. ;
Fernandez, Aileen I. I. ;
Rimm, David L. L. .
JAMA ONCOLOGY, 2023, 9 (09) :1298-1299
[28]   MET and ERBB2 Are Coexpressed in ERBB2+ Breast Cancer and Contribute to Innate Resistance [J].
Paulson, Amanda K. ;
Linklater, Erik S. ;
Berghuis, Bree D. ;
App, Colleen A. ;
Oostendorp, Leon D. ;
Paulson, Jayne E. ;
Pettinga, Jane E. ;
Melnik, Marianne K. ;
Woude, George F. Vande ;
Graveel, Carrie R. .
MOLECULAR CANCER RESEARCH, 2013, 11 (09) :1112-1121
[29]   Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer [J].
Eya Wolfson ;
Shira Solomon ;
Eran Schmukler ;
Yona Goldshmit ;
Ronit Pinkas-Kramarski .
Cell Death & Disease, 9
[30]   Aberrations of ERBB2 and TOP2A genes in breast cancer [J].
Nielsen, Kirsten Vang ;
Muller, Sven ;
Moller, Susanne ;
Schonau, Andreas ;
Balslev, Eva ;
Knoop, Ann S. ;
Ejlertsen, Bent .
MOLECULAR ONCOLOGY, 2010, 4 (02) :161-168